🇺🇸 FDA
Patent

US 11673899

Crystal form of thieno[2,3-c]pyridazine-4(1H)-one compound, preparation method therefor and use thereof

granted A61KA61K31/519A61P

Quick answer

US patent 11673899 (Crystal form of thieno[2,3-c]pyridazine-4(1H)-one compound, preparation method therefor and use thereof) held by Medshine Discovery Inc. expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Medshine Discovery Inc.
Grant date
Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/519, A61P, A61P17/10, A61P3/04